FrancophonIA/ELRC3.0 huggingface dataset:
English: Do not take Starlix if you are pregnant or planning to become pregnant.
Slovenian: Ne jemljite zdravila Starlix, če ste noseči ali če načrtujete zanositev.
English: The side effects caused by Starlix are usually mild to moderate.
Slovenian: Neželeni učinki, ki jih povzroča zdravilo Starlix, so navadno blagi do zmerni.
English: - The tablet coating contains hypromellose; titanium dioxide (E171); talc; macrogol and red (60
Slovenian: - Obloga tablete vsebuje hipromelozo; titanov dioksid (E171); smukec; makrogol in rdeči (60 in
English: Uncommon: Vomiting.
Slovenian: Občasni: bruhanje.
English: Although M1 metabolites show only slight hypoglycaemic activity (approximately 5 times lower than nateglinide), metabolite accumulation might increase the hypoglycaemic effect of the administered dose.
Slovenian: Presnovki M1 imajo sicer zelo majhno hipoglikemično aktivnost (približno 5-krat manjšo kot nateglinid), vendar kopičenje presnovkov lahko okrepi hipoglikemični učinek danega odmerka.
English: What you need to know before you take Starlix
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Starlix
English: and 180 mg tablets) or yellow (120 mg tablets) iron oxide (E172).
Slovenian: 180 mg tablete) ali rumeni (120 mg tablete) železov oksid (E172).
English: Oral antidiabetics, including Starlix, may also produce symptoms of hypoglycaemia.
Slovenian: Tudi peroralni antidiabetiki, med katerimi je tudi zdravilo Starlix, utegnejo povzročiti simptome hipoglikemije.
English: Take Starlix before meals.
Slovenian: Zdravilo Starlix jemljite pred obroki.
English: Patients with rare hereditary problems of galactose intolerance, of the Lapp lactase deficiency or of glucose-galactose malabsorption should not take this medicine.
Slovenian: Bolniki z redko dedno intoleranco za galaktozo, laponsko obliko zmanjšane aktivnosti laktaze ali malabsorpcijo glukoze/galaktoze ne smejo jemati tega zdravila.
English: Other medicines and Starlix
Slovenian: Druga zdravila in zdravilo Starlix
English: OTHER
Slovenian: Drugi
English: In rabbits, embryonic development was adversely affected and the incidence of gallbladder agenesis or small gallbladder was increased at doses of 300 and 500 mg/kg (approximately 24 and 28 times the human therapeutic exposure with a maximum recommended nateglinide dose of 180 mg, three times daily before meals), but not at 150 mg/kg (approximately 17 times the human therapeutic exposure with a maximum recommended nateglinide dose of 180 mg, three times daily before meals).
Slovenian: Pri kuncih je zdravilo škodljivo vplivalo na razvoj zarodka in povečalo pogostnost nerazvitosti žolčnika oziroma razvoja majhnega žolčnika pri odmerkih 300 oziroma 500 mg/kg (kar pomeni približno 24-kratno oziroma 28-kratno vrednost terapevtske izpostavljenosti pri človeku ob najvišjem priporočenem odmerjanju nateglinida 180 mg trikrat na dan, pred obroki), do navedenega vpliva pa ni prišlo pri odmerjanju 150 mg/kg (kar pomeni približno 17-kratno vrednost terapevtske izpostavljenosti pri človeku ob najvišjem priporočenem odmerjanju nateglinida 180 mg trikrat na dan, pred obroki).
English: Most of the [14C] nateglinide is excreted in the urine (83%), with an additional 10% eliminated in the faeces.
Slovenian: C], se izloči v urinu (83 %), dodatnih 10 % pa se ga odstrani iz telesa z blatom.
English: The decrease from baseline in HbA1c was -0.41% in the nateglinide plus metformin group and -0.57% in the gliclazide plus metformin group (difference 0.17%, [95% CI -0.03, 0.36]).
Slovenian: HbA1c se je zmanjšal od izhodišča za0,41 % v skupini z nateglinidom plus metforminom in za -0,57 % v skupini z gliklazidom plus metforminom (razlika 0,17 %, 95-odstotni interval zaupanja -0,03, 0,36).
English: Diabetic patients may develop symptoms associated with low blood sugar (also called hypoglycaemia).
Slovenian: Pri sladkornih bolnikih se včasih pojavijo simptomi, ki so povezani z znižano vrednostjo krvnega sladkorja (imenuje se tudi hipoglikemija).
English: Combination with metformin is associated with an increased risk of hypoglycaemia compared to monotherapy.
Slovenian: Pri kombinaciji z metforminom je nevarnost hipoglikemije večja kot pri monoterapiji.
English: Packs contain 12, 24, 30, 60, 84, 120 and 360 tablets.
Slovenian: Škatle vsebujejo po 12, 24, 30, 60, 84, 120 in 360 tablet.
English: Particular caution is recommended when nateglinide is co-administered with other more potent inhibitors of CYP2C9 (e.g. fluconazole, gemfibrozil or sulfinpyrazone), or in patients known to be poor metabolisers for CYP2C9 substrates.
Slovenian: Posebna previdnost je potrebna pri sočasni uporabi nateglinida z drugimi močnejšimi inhibitorji CYP2C9 (na primer s flukonazolom, z gemfibrozilom ali s sulfinpirazonom) ali pri bolnikih, za katere je znano, da imajo počasno presnovo substratov CYP2C9.
English: Nateglinide is rapidly absorbed following oral administration of Starlix tablets prior to a meal, with mean peak drug concentration generally occurring in less than 1 hour.
Slovenian: Nateglinid se po peroralnem zaužitju tablet Starlix pred obrokom hitro absorbira, povprečna najvišja koncentracija zdravila se običajno pojavi v manj kot 1 uri.
English: Common: Symptoms suggestive of hypoglycaemia.
Slovenian: Pogosti: simptomi, ki kažejo na hipoglikemijo.
English: In patients with type 2 diabetes who were given Starlix with a dose range of 60 mg to 240 mg before meals three times a day for one week, nateglinide showed linear pharmacokinetics for both AUC and Cmax.
Slovenian: Pri bolnikih s sladkorno boleznijo tipa 2, ki so en teden prejemali zdravilo Starlix v mejah odmerkov od 60 do 240 mg pred obrokom trikrat na dan, je nateglinid kazal linearno farmakokinetiko tako za AUC kot za Cmax, tmax pa je bil od odmerka neodvisen.
English: The systemic availability and half-life of nateglinide in non-diabetic subjects with mild to moderate hepatic impairment did not differ to a clinically significant degree from those in healthy subjects.
Slovenian: Sistemska uporabnost in razpolovni čas nateglinida pri nediabetikih z blago do zmerno jetrno okvaro se nista razlikovala v klinično pomembni meri od tistih pri zdravih osebah.
English: 12 film-coated tablets 24 film-coated tablets 30 film-coated tablets 60 film-coated tablets 84 film-coated tablets 120 film-coated tablets 360 film-coated tablets
Slovenian: 12 filmsko obloženih tablet 24 filmsko obloženih tablet 30 filmsko obloženih tablet 60 filmsko obloženih tablet 84 filmsko obloženih tablet 120 filmsko obloženih tablet 360 filmsko obloženih tablet
English: What Starlix is and what it is used for What you need to know before you take Starlix How to take Starlix
Slovenian: Kaj je zdravilo Starlix in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Starlix Kako jemati zdravilo Starlix Možni neželeni učinki
English: Severe hepatic impairment, children and adolescents No clinical studies have been conducted in patients with severe hepatic impairment, or in children and adolescents.
Slovenian: Pri bolnikih s hudo jetrno okvaro ter pri otrocih in mladostnikih niso bile opravljene klinične raziskave.
English: Each blister pack contains 12, 24, 30, 60, 84, 120 or 360 tablets.
Slovenian: Vsako pakiranje pretisnih omotov vsebuje 12, 24, 30, 60, 84, 120 ali 360 tablet.
English: Each tablet contains 60, 120 or 180 mg nateglinide.
Slovenian: Ena tableta vsebuje 60, 120 ali 180 mg nateglinida.
English: Other adverse events observed in clinical studies were of a similar incidence in Starlix-treated and placebo-treated patients.
Slovenian: Drugi neželeni učinki, ki so bili opaženi v kliničnih študijah, so se pojavljali podobno pogosto pri bolnikih, ki so dobivali bodisi zdravilo Starlix bodisi placebo.
English: The extent of serum protein binding is independent of drug concentration over the test range of 0.1-10 g Starlix/ml.
Slovenian: Stopnja vezave na serumske beljakovine je v mejah testiranja od 0,1 do 10 μg zdravila Starlix/ml neodvisna od koncentracije zdravila.
English: When these medicinal products - that enhance or reduce the hypoglycaemic effect of nateglinide - are administered to or withdrawn from patients receiving nateglinide, the patient should be observed closely for changes in glycaemic control.
Slovenian: Kadar so bolniku, ki jemlje nateglinid, predpisana ali ukinjena navedena zdravila, ki povečujejo ali zmanjšujejo hipoglikemično delovanje nateglinida, je treba bolnika natančno opazovati glede sprememb glikemične kontrole.
English: The systemic availability and half-life of nateglinide in diabetic patients with mild, moderate (creatinine clearance 31-50 ml/min) and severe (creatinine clearance 15-30 ml/min) renal impairment (not undergoing dialysis) did not differ to a clinically significant degree from those in healthy subjects.
Slovenian: Sistemska uporabnost in razpolovni čas nateglinida pri sladkornih bolnikih z blago, zmerno (očistek kreatinina 31-50 ml/min) in hudo (očistek kreatinina 15-30 ml/min) okvaro ledvic (ki niso na dializi), se nista razlikovala v klinično značilni meri od tistih pri zdravih osebah.
English: • feeling sick (nausea)
Slovenian: • občutek slabosti (navzeo).
English: There is no experience of an overdose of Starlix in clinical trials.
Slovenian: S prevelikim odmerjanjem zdravila Starlix v kliničnih preskušanjih ni izkušenj.
English: • Uncommon (may affect up to 1 in 100 people): vomiting
Slovenian: • občasni (lahko se pojavijo pri največ 1 od 100 ljudi): bruhanje;
English: Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential and toxicity to fertility and post-natal development.
Slovenian: Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih, genotoksičnosti, kancerogenega potenciala in toksičnosti za plodnost in postnatalni razvoj ne kažejo posebnega tveganja za človeka.
English: What Starlix contains - The active substance is nateglinide.
Slovenian: Kaj vsebuje zdravilo Starlix - Učinkovina je nateglinid.
English: Do not use any Starlix pack that is damaged or shows signs of tampering.
Slovenian: Ne uporabite zdravila Starlix, če je ovojnina poškodovana ali kaže znake, da jo je nekdo že odprl.
English: Do not stop taking Starlix unless your doctor tells you to.
Slovenian: Z jemanjem zdravila Starlix nadaljujte, dokler vam zdravnik ne naroči, da ga prenehajte jemati.
English: The recommended starting dose of Starlix is 60 mg three times daily, taken before each of the three main meals.
Slovenian: Priporočeni začetni odmerek zdravila Starlix je 60 mg trikrat na dan, pred vsakim od treh glavnih obrokov.
English: Elderly Age did not influence the pharmacokinetic properties of nateglinide.
Slovenian: Starejši bolniki Starost ni vplivala na farmakokinetične lastnosti nateglinida.
English: Rare: Hypersensitivity reactions such as rash, itching and urticaria.
Slovenian: Redke: preobčutljivostne reakcije, na primer izpuščaj, srbenje in koprivnica.
English: If you forget to take Starlix
Slovenian: Če ste pozabili vzeti zdravilo Starlix
English: Your doctor will prescribe Starlix together with metformin, if inadequately controlled despite a maximally tolerated dose of metformin.
Slovenian: Zdravnik vam bo predpisal zdravilo Starlix skupaj z metforminom, če vrednosti sladkorja v krvi pri vas niso urejene kljub najvišjemu odmerku metformina, ki ga še prenašate.
English: No clinically significant differences in nateglinide pharmacokinetics were observed between men and women.
Slovenian: Spol Med moškimi in ženskami niso opažene klinično pomembne razlike v farmakokinetiki nateglinida.
English: Although there is a 49% decrease in Cmax of nateglinide in dialysis patients, the systemic availability and half-life in diabetic subjects with moderate to severe renal insufficiency (creatinine clearance 15-50 ml/min) was comparable between renal subjects requiring haemodialysis and healthy subjects.
Slovenian: Čeprav se pri dializnih bolnikih Cmax nateglinida zmanjša za 49 %, sta bila pri sladkornih bolnikih z zmerno do hudo ledvično insuficienco (z očistkom kreatinina 15-50 ml/min) sistemska uporabnost in razpolovni čas primerljiva med ledvičnimi bolniki, ki potrebujejo hemodializo, in zdravimi osebami.
English: It is recommended that Starlix be administered prior to meals.
Slovenian: Zdravilo Starlix je priporočljivo jemati pred obroki.
English: Do not take Starlix - if you are allergic to nateglinide or any of the other ingredients of this medicine (listed in section 6).
Slovenian: Ne jemljite zdravila Starlix - če ste alergični na nateglinid ali katero koli sestavino tega zdravila (navedeno v poglavju 6); - če imate sladkorno bolezen tipa 1 (tj., če vaše telo sploh ne izdeluje insulina);
English: Diuretics, corticosteroids, beta2 agonists, somatropin, somatostatin analogues, rifampin, phenytoin and St. John's Wort (Hypericum perforatum)
Slovenian: Diuretiki, kortikosteroidi, agonisti adrenergičnih receptorjev beta2, somatotropin, analogi somatostatina, rifampicin, fenitoin in šentjanževka (Hypericum perforatum)
English: Therefore, dose discontinuation is advisable in patients with severe renal impairment who present with potentiation of hypoglycaemic effect while on Starlix.
Slovenian: Iz tega razloga je priporočljivo odmerjanje zdravila prekiniti pri tistih bolnikih s hudo okvaro ledvic, pri katerih prihaja do močnejšega hipoglikemičnega učinka v času jemanja zdravila Starlix.
English: If you stop taking Starlix
Slovenian: Če ste prenehali jemati zdravilo Starlix
English: Combination with ACE-inhibitors, NSAIDs, salicylates, monoamine oxidase inhibitors, non-selective beta-adrenergic-blocking agents and anabolic hormones
Slovenian: Uporaba v kombinaciji z zaviralci angiotenzinske konvertaze, nesteroidnimi protivnetnimi zdravili, salicilati, zaviralci monoamin-oksidaze, neselektivnimi zaviralci adrenergičnih receptorjev beta ali anabolnimi hormoni
English: Excipient with known effect Lactose monohydrate: 141.5 mg per tablet.
Slovenian: Pomožna snov z znanim učinkom: laktoza monohidrat: 141,5 mg na tableto.
English: What Starlix is The active substance of Starlix, nateglinide, belongs to a group of medicines called oral antidiabetics.
Slovenian: Učinkovina v zdravilu Starlix, nateglinid, sodi v skupino zdravil, ki jih imenujemo peroralni antidiabetiki.
English: The maximum recommended dose is 180 mg three times daily, taken before each of the three main meals.
Slovenian: Najvišji priporočeni odmerek je 180 mg trikrat na dan, pred vsakim od treh glavnih obrokov.
English: However, there is a delay in the rate of absorption characterised by a decrease in Cmax and a delay in time to peak plasma concentration (tmax).
Slovenian: Jemanje nateglinida po obroku ne vpliva na obseg njegove absorpcije (AUC), vendar se absorpcija upočasni, kar se pokaže kot znižana Cmax in podaljšan čas do najvišje koncentracije v plazmi (tmax).
English: Starlix tablets contain lactose monohydrate.
Slovenian: Tablete Starlix vsebujejo laktozo monohidrat.
English: • weakness
Slovenian: • oslabelost,
English: Excipient with known effect Lactose monohydrate: 283 mg per tablet.
Slovenian: Pomožna snov z znanim učinkom: laktoza monohidrat: 283 mg na tableto
English: How Starlix works
Slovenian: Kako zdravilo Starlix deluje
English: The following agents may enhance the hypoglycaemic effect of nateglinide: angiotensin-converting enzyme inhibitors (ACEI), non-steroidal anti-inflammatory agents, salicylates, monoamine oxidase inhibitors, non-selective beta-adrenergic-blocking agents and anabolic hormones (e.g. methandrostenolone).
Slovenian: Hipoglikemično delovanje nateglinida lahko povečajo sledeča zdravila: zaviralci angiotenzinske konvertaze (ACEI), nesteroidna protivnetna zdravila, salicilati, zaviralci monoamin-oksidaze, neselektivni zaviralci adrenergičnih receptorjev beta in anabolni hormoni (na primer metandrostenolon).
English: Repeated dosing with 90 mg once daily for 1 to 3 months in diabetic patients with end-stage renal disease (ESRD) showed pronounced M1 metabolite accumulation up to 1.2 ng/ml despite the reduced dose.
Slovenian: Pri bolnikih s sladkorno boleznijo in končno ledvično odpovedjo (KLO) je pri večkratnem odmerjanju 90 mg enkrat na dan v obdobju od 1 do 3 mesecev kljub zmanjšanemu odmerjanju prišlo do izrazitega kopičenja presnovka M1 do 1,2 ng/ml.
English: The following agents may reduce the hypoglycaemic effect of nateglinide: diuretics, corticosteroids, beta2 agonists, somatropin, somatostatin analogues (e.g. lanreotide, octreotide), rifampin, phenytoin and St. John's Wort (Hypericum perforatum).
Slovenian: Hipoglikemično delovanje nateglinida lahko zmanjšajo sledeča sredstva: diuretiki, kortikosteroidi, agonisti adrenergičnih receptorjev beta2, somatotropin, analogi somatostatina (na primer lanreotid, oktreotid), rifampicin, fenitoin in šentjanževka (Hypericum perforatum).
English: Excipient with known effect Lactose monohydrate: 214 mg per tablet.
Slovenian: Pomožna snov z znanim učinkom: laktoza monohidrat: 214 mg na tableto
English: If you have any further questions on the use of this medicine, talk to your doctor, pharmacist or nurse.
Slovenian: Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: • Rare (may affect up to 1 in 1,000 people): mild abnormalities in liver function tests, allergic
Slovenian: • redki (lahko se pojavijo pri največ 1 od 1.000 ljudi): nekoliko nenormalne vrednosti testov jetrne funkcije, alergijske (preobčutljivostne) reakcije, kot sta izpuščaj ali srbenje;
English: Starlix contains lactose
Slovenian: Zdravilo Starlix vsebuje laktozo
English: Thus, no dosage adjustment is required for digoxin, warfarin or other drugs that are CYP2C9 or CYP3A4 substrates upon coadministration with Starlix.
Slovenian: Zato pri sočasni uporabi z zdravilom Starlix pri digoksinu, varfarinu in drugih zdravilih, ki so substrati CYP2C9 ali CYP3A4, ni potrebno prilagajanje odmerjanja.
English: • Common (may affect up to 1 in 10 people): abdominal pain, indigestion, diarrhoea, nausea
Slovenian: • pogosti (lahko se pojavijo pri največ 1 od 10 ljudi): bolečine v trebuhu, prebavne motnje drisko in občutek slabosti;
English: - The other ingredients are lactose monohydrate; cellulose, microcrystalline; povidone;
Slovenian: - Druge sestavine zdravila so laktoza monohidrat; mikrokristalna celuloza; povidon; premrežen natrijev karmelozat; magnezijev stearat in brezvodni koloidni silicijev dioksid.
English: - if you are experiencing any symptoms of severe hyperglycaemia (very high blood sugar and/or diabetic ketoacidosis).
Slovenian: - če imate simptome hude hiperglikemije (zelo visoke vrednosti krvnega sladkorja in/ali diabetične ketoacidoze), ki vključujejo hudo žejo, pogosto uriniranje, šibkost, utrujenost,
English: - if you have a severe kidney problem.
Slovenian: • s hudo jetrno okvaro.
English: Each film-coated tablet contains 60 mg nateglinide.
Slovenian: Ena filmsko obložena tableta vsebuje 60 mg nateglinida.
English: Nateglinide should be used with caution in patients with moderate hepatic impairment.
Slovenian: Okvara jeter Pri bolnikih z zmerno jetrno okvaro je treba nateglinid uporabljati previdno.
English: EU/1/01/174/015 12 film-coated tablets EU/1/01/174/016 24 film-coated tablets EU/1/01/174/017 30 film-coated tablets EU/1/01/174/018 60 film-coated tablets EU/1/01/174/019 84 film-coated tablets EU/1/01/174/020 120 film-coated tablets EU/1/01/174/021 360 film-coated tablets
Slovenian: EU/1/01/174/015 12 filmsko obloženih tablet EU/1/01/174/016 24 filmsko obloženih tablet EU/1/01/174/017 30 filmsko obloženih tablet EU/1/01/174/018 60 filmsko obloženih tablet EU/1/01/174/019 84 filmsko obloženih tablet EU/1/01/174/020 120 filmsko obloženih tablet EU/1/01/174/021 360 filmsko obloženih tablet
English: EU/1/01/174/001 12 film-coated tablets EU/1/01/174/002 24 film-coated tablets EU/1/01/174/003 30 film-coated tablets EU/1/01/174/004 60 film-coated tablets EU/1/01/174/005 84 film-coated tablets EU/1/01/174/006 120 film-coated tablets EU/1/01/174/007 360 film-coated tablets
Slovenian: EU/1/01/174/001 12 filmsko obloženih tablet EU/1/01/174/002 24 filmsko obloženih tablet EU/1/01/174/003 30 filmsko obloženih tablet EU/1/01/174/004 60 filmsko obloženih tablet EU/1/01/174/005 84 filmsko obloženih tablet EU/1/01/174/006 120 filmsko obloženih tablet EU/1/01/174/007 360 filmsko obloženih tablet
English: How to take Starlix
Slovenian: Kako jemati zdravilo Starlix
English: Talk to your doctor before taking Starlix - if you know that you have a liver problem.
Slovenian: Pred začetkom jemanja zdravila Starlix se posvetujte z zdravnikom, - če veste, da imate težave z jetri, - če imate hude težave z ledvicami, - če imate težave s presnavljanjem zdravil, - če boste morali biti operirani, - če ste imeli pred kratkim zvišano telesno temperaturo, nezgodo ali okužbo.
English: EU/1/01/174/008 12 film-coated tablets EU/1/01/174/009 24 film-coated tablets EU/1/01/174/010 30 film-coated tablets EU/1/01/174/011 60 film-coated tablets EU/1/01/174/012 84 film-coated tablets EU/1/01/174/013 120 film-coated tablets EU/1/01/174/014 360 film-coated tablets
Slovenian: EU/1/01/174/008 12 filmsko obloženih tablet EU/1/01/174/009 24 filmsko obloženih tablet EU/1/01/174/010 30 filmsko obloženih tablet EU/1/01/174/011 60 filmsko obloženih tablet EU/1/01/174/012 84 filmsko obloženih tablet EU/1/01/174/013 120 filmsko obloženih tablet EU/1/01/174/014 360 filmsko obloženih tablet
English: You should ask for doctor advice on driving if you have frequent episodes of hypoglycaemia or if you are not aware of the first signs of hypoglycaemia.
Slovenian: Če imate pogoste hipoglikemije ali ne zaznavate prvih znakov hipoglikemije, se morate glede vožnje posvetovati z zdravnikom.
English: The recommended maximum daily dose is 180 mg three times daily to be taken before the three main meals.
Slovenian: Priporočeni največji dnevni odmerek je 180 mg, ki ga bolnik vzame pred tremi glavnimi obroki.
English: Other events
Slovenian: Drugi učinki
English: Each film-coated tablet contains 180 mg nateglinide.
Slovenian: Ena filmsko obložena tableta vsebuje 180 mg nateglinida.
English: Starlix contains lactose monohydrate.
Slovenian: Zdravilo Starlix vsebuje laktozo monohidrat.
English: Each film-coated tablet contains 120 mg nateglinide.
Slovenian: Ena filmsko obložena tableta vsebuje 120 mg nateglinida.
English: Its effect may be delayed if it is taken during or after meals.
Slovenian: Če bi ga jemali v vmesnem času ali po obrokih, bi delovalo počasneje.
English: Take Starlix before meals (see section 3, “How to take Starlix”); its effect may be delayed if it is taken during or after meals.
Slovenian: Zdravilo Starlix skupaj s hrano, pijačo in alkoholom Zdravilo Starlix jemljite pred obroki (glejte poglavje 3 "Kako jemati zdravilo Starlix").
English: Discontinuation should be considered in patients with severe renal impairment who present with potentiation of the hypoglycaemic effect.
Slovenian: Pri bolnikih s hudo okvaro ledvic, pri katerih prihaja do močnejšega hipoglikemičnega učinka, je treba razmisliti o prekinitvi odmerjanja zdravila.
English: - if you have another medical condition that may cause low blood sugar (e.g. an under-active pituitary or adrenal gland).
Slovenian: Previdnost je potrebna, - če ste starejši od 65 let, - če ste podhranjeni, - če imate drugo bolezen, ki utegne povzročati nizek krvni sladkor (npr. premalo dejavno hipofizo ali nadledvično žlezo).
English: Starlix 60 mg film-coated tablets Starlix 120 mg film-coated tablets Starlix 180 mg film-coated tablets nateglinide
Slovenian: Starlix 60 mg filmsko obložene tablete Starlix 120 mg filmsko obložene tablete Starlix 180 mg filmsko obložene tablete nateglinid
English: STARLIX 60 mg film-coated tablets STARLIX 120 mg film-coated tablets STARLIX 180 mg film-coated tablets
Slovenian: STARLIX 60 mg filmsko obložene tablete STARLIX 120 mg filmsko obložene tablete STARLIX 180 mg filmsko obložene tablete
English: 60 mg pink, round, bevelled-edge tablets with “STARLIX” marked on one side and “60” on the other.
Slovenian: 60 mg rožnate, okrogle tablete z zaobljenimi robovi in oznako “STARLIX” na eni ter “60” na drugi strani.
English: Starlix 60 mg tablets nateglinide
Slovenian: Starlix 60 mg tablete nateglinid